Ningbo Sanxing Medical Electric Co (601567) Q1 2026 earnings summary

Executive summary

• Revenue for Q1 2026 was RMB 3.24 billion, down 10.84% year-over-year.

• Net profit attributable to shareholders was RMB 167 million, a 65.80% decrease year-over-year.

• Decline mainly due to lower revenue in the intelligent power distribution segment and fluctuations in bidding and raw material prices.

Financial highlights

• Operating income: RMB 3.24 billion, down from RMB 3.63 billion year-over-year.

• Total profit: RMB 208 million, down 63.36% year-over-year.

• Net profit attributable to shareholders: RMB 167 million, down 65.80% year-over-year.

• Basic and diluted EPS: RMB 0.12, down 65.71% year-over-year.

• Operating cash flow turned positive at RMB 14.35 million, compared to negative RMB 148.43 million last year.

• Total assets at quarter-end: RMB 25.36 billion, down 1.65% from year-end 2025.

Outlook and guidance

• Order backlog at quarter-end was RMB 15.74 billion, up 0.15% year-over-year.

• Overseas power distribution orders grew 37.66% year-over-year to RMB 2.295 billion.